Results 71 to 80 of about 35,022 (298)

Role of Early Assesment of Diuresis and Natriuresis in Detecting In-Hospital Diuretic Resistance in Acute Heart Failure

open access: yesFrontiers in Physiology, 2022
Background and Purpose: European Guidelines recommend early evaluation of diuresis and natriuresis after the first administration of diuretic to identify patients with insufficient diuretic response during acute heart failure.
Belén García-Magallón   +21 more
doaj   +1 more source

Risk of Acute Kidney Injury Associated With Nephrotoxic Burden in Hospitalized Patients: A Scoping Review

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Limited evidence exists synthesizing the risk of acute kidney injury (AKI) associated with the concomitant administration of multiple nephrotoxic drugs, and even less examining the concept of nephrotoxic burden. The objective of this scoping review was to (1) identify definitions of nephrotoxic burden; (2) methods used to quantify (use of calculations)
Wafa Alatawi   +6 more
wiley   +1 more source

The potential toxicity of loop diuretics in patients with cardiovascular complications

open access: yesJournal of Education, Health and Sport, 2018
A patient with cardiovascular complications is a proper candidate for a diuretic treatment. Here, loop diuretics are the drugs with the greatest strength and time of acting, especially when used in urgent cases like exacerbation of heart failure is ...
Grzegorz Liczner   +5 more
doaj   +3 more sources

Diuretic treatment in chronic heart failure [PDF]

open access: yesRomanian Journal of Medical Practice, 2016
Heart failure is a major public health problem in developed countries. Many of the clinical manifestations of heart failure are due to congestion and fluid retention, therefore diuretic therapy occupied for a long time an important place in the ...
Camelia C. DIACONU   +2 more
doaj   +1 more source

Loop Diuretics and Sarcopenia: A Potential Association [PDF]

open access: diamond, 2023
Nikolaos D. Karakousis   +1 more
openalex   +1 more source

Incident heart failure: comparing management and outcome in primary and hospital settings in Western Sweden 2008–2017

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 832-838, April 2025.
Abstract Aim Heart failure (HF) is a highly prevalent condition managed in both primary care (PC) and hospital care (HC)‐based settings. HF patients managed in these two settings may differ in their demography, comorbidities and outcomes, so we aimed to compare the patient management in PC and HC in the Västra Götaland Region (VGR) in Sweden.
Xiaojing Chen   +4 more
wiley   +1 more source

A practical approach to sequential nephron blockade in acute decompensated heart failure

open access: yesRomanian Journal of Cardiology, 2023
Acute decompensated heart failure (ADHF) is a worldwide health problem, with poor prognosis and significant morbidity and mortality. Fluid overload is the primary reason for hospitalization in ADHF.
Frățilă Georgiana-Valentina   +2 more
doaj   +1 more source

Diuretic resistance and the role of albumin in congestive heart failure

open access: yesDrugs in Context, 2023
Diuresis with loop diuretics is the mainstay treatment for volume optimization in patients with congestive heart failure, in which perfusion and volume expansion play a crucial role.
Carol Fernandez Hazim   +6 more
doaj   +1 more source

Randomised controlled trial of specialist nurse intervention in heart failure [PDF]

open access: yes, 2001
<p>Objectives. To determine whether specialist nurse intervention improves outcome in patients with chronic heart failure.</p> <p>Design. Randomised controlled trial.</p> <p>Setting.
Blue, L.   +11 more
core   +2 more sources

Transthyretin amyloid cardiomyopathy: Literature review and red‐flag symptom clusters for each cardiology specialty

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 955-967, April 2025.
Abstract Wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM) is a progressive and infiltrative cardiac disorder that may cause fatal consequences if left untreated. The estimated survival time from diagnosis is approximately 3–6 years. Because of the non‐specificity of initial symptom manifestation and insufficient awareness among treating ...
Yasuhiro Izumiya   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy